These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3096356)

  • 1. Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    ASAIO Trans; 1986; 32(1):35-8. PubMed ID: 3096356
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    Adv Perit Dial; 1989; 5():111-20. PubMed ID: 2577390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced peritoneal fibrosis in CAPD. Effects of Ca++ and 1,25(OH)2D3.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    ASAIO Trans; 1989; 35(3):418-20. PubMed ID: 2512968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S; Nasini MG
    ASAIO Trans; 1987; 33(3):657-63. PubMed ID: 3118927
    [No Abstract]   [Full Text] [Related]  

  • 6. A biocompatibility study on peritoneal dialysis solution bags for CAPD.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
    Adv Perit Dial; 1993; 9():138-42. PubMed ID: 8105908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis solution calcium concentration regulates peritoneal fibroblast proliferation in CAPD.
    Carozzi S; Nasini MG; Cantaluppi A; Salit M
    ASAIO J; 1992; 38(3):M585-8. PubMed ID: 1457927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lympho-monokine disorders in continuous ambulatory peritoneal dialysis.
    Carozzi S
    Contrib Nephrol; 1990; 86():128-39. PubMed ID: 2127738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary function in uremic patients treated with continuous ambulatory peritoneal dialysis (CAPD)].
    Gómez Fernández P; Miguel Alonso JL; Sánchez Agudo L; Calatrava JM; Conesa J; Sánchez Sicilia L
    Med Clin (Barc); 1982 Sep; 79(5):219-23. PubMed ID: 7144303
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis (CAPD).
    Swartz RD
    Compr Ther; 1983 Aug; 9(8):54-60. PubMed ID: 6617129
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis.
    Carozzi S; Salit M; Cantaluppi A; Nasini MG; Barocci S; Cantarella S; Lamperi S
    J Clin Microbiol; 1989 Aug; 27(8):1748-53. PubMed ID: 2504774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ concentration in the peritoneal dialysis solution regulates peritoneal fibroblast proliferation and peritoneal macrophage and lymphocyte cytokine release.
    Carozzi S; Nasini MG
    Perit Dial Int; 1993; 13 Suppl 2():S41-4. PubMed ID: 8399626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of monophosphoryl lipid A (MPLA) on peritoneal leukocyte function.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Cantarella S; Versace F; Salit M; Cantaluppi A
    Adv Perit Dial; 1989; 5():143-50. PubMed ID: 2577398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
    Grzegorzewska A; Sliwowski A
    Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis.
    Tsai TC; Hsu JC; Chou LH; Lee ML
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):455-9. PubMed ID: 7942034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous ambulatory peritoneal dialysis. 5-year clinical experience].
    Fuchs C; Dorn D; Bleckmann C; Gottschaldt M; Scheler F
    Dtsch Med Wochenschr; 1985 Feb; 110(5):163-7. PubMed ID: 3967602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
    Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.